Phase 2 dose-finding data The phase 2 trial tested cagrilintide at 0.3 mg, 0.6 mg, 1.2 mg, 2.4 mg, and 4.5 mg weekly
doi:10.1016/j.yrtph.2020.104665 Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JHS
The overall quality of evidence for this outcome was low due to serious imprecision (low number of trials and participants)
This means: It is banned in-competition and out-of-competition Detection in drug testing can result in suspension, disqualification, or loss of eligibility BPC-157 is not typically detected in standard panels , but advanced screens may be used at the elite level Any pharmacological substance which is not addressed by any of the subsequent sections of the list and with no current approval by any governmental regulatory health authority for human therapeutic use is prohibited. World Anti-Doping Agency (WADA), Prohibited List International Status The legality of BPC-157 varies widely by country
Storage Guidelines Store lyophilised peptide in a cool, dry place away from light
Researchers study DSIP to investigate its potential roles in sleep modulation, stress response, pain control, and hormone secretion (LH, GH, ACTH)